SINGLE ANTIPLATELET THERAPY
Clinical trials for SINGLE ANTIPLATELET THERAPY explained in plain language.
Never miss a new study
Get alerted when new SINGLE ANTIPLATELET THERAPY trials appear
Sign up with your email to follow new studies for SINGLE ANTIPLATELET THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart stent patients: could a tailored blood thinner dose prevent clots and bleeding?
Disease control Recruiting nowThis study looks for the best type and dose of blood thinner (P2Y12 inhibitor) for people who have had a heart stent placed. After an initial period on two blood thinners, patients switch to one. The goal is to find a dose that keeps blood clotting at a safe level—not too high (w…
Matched conditions: SINGLE ANTIPLATELET THERAPY
Phase: PHASE3 • Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether taking just one blood thinner (single antiplatelet therapy) is safer and as effective as taking two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a balloon procedure to open blocked heart arteries. About 576…
Matched conditions: SINGLE ANTIPLATELET THERAPY
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC